Home Articoli Biotecnologie

Biotecnologie

Filtro titolo     Mostra # 
# Titolo articolo Visite
1 Label change for Elan's MS-drug permits safer use 7
2 Label change for Elan's MS-drug permits safer use 6
3 Novartis loves and fears EMA 4
4 Novartis loves and fears EMA 3
5 4SC gets a confidence boost in clinic and stockmarket 3
6 4SC gets a confidence boost in clinic and stockmarket 4
7 Swedish DuoCort Pharma snatched up by US Viropharma 35
8 Novartis fails with Phase III osteoporosis drug 110
9 Digna Biotech regains rights for inhibitor for systemic skin sclerosis 17
10 GSK launches €36 million life sciences fund for Canada 29
11 GSK launches 36 million life sciences fund for Canada 7
12 Merck Serono cheers Ablynx up with nanobodies pact 25
13 inventore vescica biotech, presto 30 organi 24
14 Record attendance at BIO-Europe 15
15 Drop in biotech investments in Europe 18
16 Drop in biotech investments in Europe 22
17 Cellectis approves €50m takeover of Swedish Cellartis 16
18 Cellectis approves €50m takeover of Swedish Cellartis 17
19 Cellectis approves 50m takeover of Swedish Cellartis 9
20 Biotie axes acquisition of Newron 25
21 Biotie axes acquisition of Newron 20
22 Eli Lilly sounds retreat on Xigris 23
23 EMOFILIA: CREATA NUOVA PROTEINA BIOTECH PROMETTENTE 35
24 Pronova opens up Japanese market 27
25 Rovi and Ferrer build national Spanish vaccine plant 33
26 Biotie buys Newron 42
27 Bayer and Evogene reach milestone in wheat traits 33
28 First stem cell trial in Europe 34
29 Bayer tanks after doubts over Xarelto 36
30 Amakem Raises €18m in a Series A Round 28
31 Amakem Raises 18m in a Series A Round 18
32 Creathor collects €51 million in 3rd life sciences fund 33
33 Creathor collects 51 million in 3rd life sciences fund 18
34 Depression and other mental disorders are Europe’s largest health challenge, study concludes 35
35 Depression and other mental disorders are Europes largest health challenge, study concludes 26
36 French Rhenovia leads project to evaluate the effects of neurotoxins to military personnel 46
37 GMO Field trial forbidden in Spain 39
38 GE Healthcare acquires PAA Laboratories 43
39 Evolva secures €30m financing line 37
40 Evolva secures 30m financing line 23
41 Novartis would-be-daughter Proteon raises $15.2 million 51
42 Lundbeck cuts R&D and raises profits 36
43 MANOVRA:ASSOBIOTEC,NUOVA STANGATA A INDUSTRIA BIOTECNOLOGICA 75
44 ASCO: Avastin halves disease progression in recurrent ovarian cancer 40
45 Antibody blocks cytokine that drives atherosclerosis 55
46 Direct-to-consumer genetic tests under fire from geneticists 59
47 Elan sign US$50m development deal with Proteostasis Therapeutics 64
48 Actelion reaches proof-of-concept in allergic rhinitis 63
49 Actelion reaches proof-of-concept in allergic rhinitis 54
50 Genetic engineered trees double bio-ethanol yield 60
51 Genetic engineered trees double bio-ethanol yield 73
52 DOMPE', IN ITALIA CRESCITA BIOTECH DA 5% A 10% ANNO 75
53 Evotec and Roche terminate proof-of-concept study with EVT101 38
54 Evotec and Roche terminate proof-of-concept study with EVT101 57
55 Pronova’s hypertriglyceridemia drug TAK-085 superior to EPA in Phase III trial 54
56 Pronovas hypertriglyceridemia drug TAK-085 superior to EPA in Phase III trial 45
57 BioAmber raises $45M to expand its succinic acid platform 51
58 Selvita Completes $ 5.5 Million Private Placement 58
59 Algeta targets breast cancer and angiogenesis through research pact with Affibody 100
60 Molecular Partners signs US$420 million contract on antibody mimetic with Allergan 96
61 Biotecnologie in Italia: secondo il Rapporto 2011 in un anno fatturato in crescita in Europa del 6% 48
62 Biotecnologie in Italia: secondo il Rapporto 2011 in un anno fatturato in crescita in Europa del 6% 59
63 IN ITALIA 375 AZIENDE, TUTTE IN CRESCITA PICCOLE E HI-TECH, AL PRIMO POSTO PER INVESTIMENTI 81
64 IN ITALIA 375 AZIENDE, TUTTE IN CRESCITA PICCOLE E HI-TECH, AL PRIMO POSTO PER INVESTIMENTI 42
65 Battered Sanofi sets hopes on cancer and biotech 57
66 Pieris and Daiichi Sankyo sign EUR207m Anticalin deal 68
67 BIOTECH: CREATO STRUMENTO ANTIBIOTERRORISMO, SCOVA RISCHI 82
68 BIOTECH: CREATO STRUMENTO ANTIBIOTERRORISMO, SCOVA RISCHI 106
69 Italian PET producer M&G builds first industrial lignocellulosic bioethanol plant 80
70 Novartis terminates Tasigna study in GIST 100
71 German researchers kick-off National Biobank Initiative 58
72 Astex-Supergen merger set to create cancer leader 53
73 Astex-Supergen merger set to create cancer leader 55
74 Swiss biotech sector reports positive key figures for 2010 47
75 Swiss biotech sector reports positive key figures for 2010 64
76 NATI BATTERI DIRIGIBILI CHE FANNO E SPARANO FARMACI 64
77 ISTITUTO RIZZOLI SI ALLEA CON LIFENET HEALTH 146
78 MALATTIE RARE:ASSOBIOTEC, SOSTENERE RICERCA IN BIOTECNOLOGIE 69
79 Sanofi-Aventis signs second-largest biotech deal ever 44
80 Sanofi-Aventis signs second-largest biotech deal ever 83
81 Philogen cancels IPO after Bayer terminates partnership 57
82 Philogen cancels IPO after Bayer terminates partnership 43
83 Researcher resensitize solid tumors to cell death 63
84 EU researchers start building data warehouse for personalised cancer care 70
85 Photodynamic therapy blocks spread of cancer 71
86 Researchers find blood pressure sensor in the liver 69
87 New EU project could help reduce animal testing 65
88 Novartis strengthens its MolDx business by $470 million acquisition 71
89 Estrogen blockage reduces risk of dying from lung cancer 70
90 Merck Serono kicks off partnership with Domain Therapeutics in Parkinson Disease 60
91 Researchers find molecular switch that directs proinflammatory response 67
92 Researchers find way to fix GPCRs for structural analyses 61
93 Qiagen to acquire stake in Alacris 69
94 Researchers demonstrate utility of transcript replacement therapy 67
95 GlaxoSmithKline licences T cell modulator IMP731 for the treatment of autoimmune diseases 74
96 Novartis researchers find biomarker for therapy response in Fragile X syndrome 68
97 Pfizer expands LNA drug development alliance with Santaris Pharma A/S 67
98 Orexo bags milestone for novel painkiller candidate from Boehringer Ingelheim 73
99 DSM broadens biocatalysis platform with c-LEcta enzymes 74
100 BASF and AVEBE collaborate to optimize amylopectin starch potatoes 59
101 Addex wins EuropaBio’s European Biotech SME Award 75
102 IMPRESE: ASSOBIOTEC, BIOTECH SPICCA PER INNOVAZIONE 108
103 Dabigatran demonstrates better safety than warfarin in stroke prevention 82
104 LA FDA CONFERMA: IL SALMONE BIOTECH E' SICURO 102
105 APEIRON NOMINATED FOR THE MOST IMPORTANT EUROPEAN BIOTECHNOLOGY AWARD 91
106 ITALIA-ISRAELE: BIOMED NUOVA FRONTIERA COOPERAZIONE 102
107 TUMORI:RISULTATI TEST FANNO IMPENNARE AZIONI AZIENDE BIOTECH 102
108 CREATA PROTEINA SINTETICA PER RIPARARE I MUSCOLI 139
109 DIABETE:BENE ESPERIMENTO TRAPIANTO CELLULE DA MAIALE A UOMO 137
110 USA: COMMISSIONE PROPONE STOP AI BREVETTI SUI GENI DIAGNOSTICI 100
111 TUMORI: BIOBANCHE IN RETE NEL FUTURO DI NERVIANO 124
112 CIVICO DI PALERMO CREA CENTRO BIOTECNOLOGIA IN SERBIA 108
113 BIOTECH:MUSCOLI ARTIFICIALI PER 'RIANIMARE' VISO PARALIZZATO 220
114 Nasce nuovo Centro per le Biotecnologie e la Ricerca Biomedica a Palermo. 207
115 HI-TECH: MANO BIONICA IMPIANTATA A STUDENTE INGLESE 102
116 DIABETE: SPERIMENTATA INSULINA DA PIANTE BIOTECH 107
117 ASMA: TORNA RIMBORSABILE NUOVO FARMACO BIOTECNOLOGICO 183
118 AIDS: CON STAMINALI PELLE BIOTECH SI STUDIA CURA ANTI HIV 100
119 IMPOTENZA: TOCCHERA' 322 MLN NEL 2025, UN AIUTO DA PROTESI 111
Links Consigliati
Donazioni libere
Cerca nel sito
Chi è online?
 21 visitatori online
Statistiche sito
OS : Linux w
PHP : 5.3.3-7+squeeze1
MySQL : 5.1.49-3
Ora : 05:49
Caching : Disattivato
GZIP : Disattivato
Utenti : 1
Contenuti : 9569
Link web : 22
Tot. visite contenuti : 736751
Articoli recenti
Articoli più letti

Copyright © 2010 Farmacistasostituzione.it
TheChinaStudy.eu